Early safety check: how does a new drug behave in people with liver issues?
NCT ID NCT07248839
Summary
This early-stage study aims to understand how a new drug called BMS-986435 is processed by the body in people with normal liver function and those with mild to moderate liver impairment. The study will enroll 24 participants to measure drug levels in the blood and monitor for safety. This information helps researchers determine if liver function affects how the drug should be dosed in future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Conditions
Explore the condition pages connected to this study.